Bonus BioGroup Ltd. (TLV:BONS)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
42.50
-0.50 (-1.16%)
Apr 28, 2026, 5:24 PM IDT
138.76%
Market Cap 496.46M
Revenue (ttm) n/a
Net Income (ttm) -24.49M
Shares Out 1.17B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,757,720
Average Volume 1,223,957
Open 43.70
Previous Close 43.00
Day's Range 40.00 - 43.80
52-Week Range 17.80 - 60.90
Beta 0.85
RSI 53.63
Earnings Date Apr 13, 2026

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 37
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BONS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.